Streetbeat News

MRMD

MariMed Inc

Employees

326

Industry

Medicinal and Botanical Manufacturing

Open

0.16

Mkt cap

60M

Volume

225K

High

0.17

P/E Ratio

-3.15

52-wk high

0.39

Low

0.15

Div yield

N/A

52-wk low

0.14

Marijuana stocks experienced a bullish Monday with several companies seeing significant gains. Notable gainers include Genetic Technologies (NASDAQ:GENE) and Aurora Cannabis (NASDAQ:ACB). However, some companies like Currenc Group (NASDAQ:CURR) saw declines.

Portfolio Pulse from Benzinga Insights

October 14, 2024 | 8:30 pm

The article discusses the importance of emotional connection with consumers for cannabis brands, as highlighted by industry experts at the Benzinga Cannabis Capital Conference. Key figures from iAnthus Capital Holdings, MariMed, Wana Brands, and Ayr Wellness emphasized understanding consumer needs and creating a strong brand identity. The role of budtenders and the shift towards effect-based cannabis understanding were also discussed.

Portfolio Pulse from Jelena Martinovic

October 14, 2024 | 4:52 pm

The article discusses the changes in consensus 2024 EBITDA estimates for cannabis companies, noting a general downward revision of 4.5% year-to-date. Despite this, estimates are still 8.4% above 2023 levels. MariMed saw a significant downward revision, while Trulieve experienced an upward revision. The article highlights the challenges faced by the cannabis sector, including rising costs and capital scarcity, and emphasizes the need for patience among investors.

Portfolio Pulse from Viridian Capital Advisors

October 14, 2024 | 3:56 pm

The article reports on the stock movements of various marijuana-related companies for October 11, 2024. Notable gainers include Elixinol Wellness, Pharmadrug, and GrowGeneration, while significant losers include Rocky Mountain High and Maple Leaf Green World.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 8:30 pm

On October 7, 2024, several marijuana stocks experienced significant price movements. Notable gainers included Affinor Growers, Pharmadrug, and Charlotte's Web Holdings, while SOL Global Investments, 4Front Ventures, and Zoned Properties were among the losers. Genetic Technologies and Eastside Distilling, both listed on NASDAQ, also saw price changes.

Portfolio Pulse from Benzinga Insights

October 07, 2024 | 8:30 pm

Curaleaf and MariMed, two major cannabis companies, are set to report their Q3 2024 earnings on November 6. Curaleaf has been expanding internationally, while MariMed is focusing on margin expansion and new assets. Both companies' executives will speak at the Benzinga Cannabis Conference.

Portfolio Pulse from Jelena Martinovic

October 07, 2024 | 3:31 pm

Banzai has been granted an extension by the Nasdaq Hearing Panel to regain compliance with listing requirements.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 12:34 pm

The cannabis sector experienced a bullish sentiment on September 23, 2024, with several stocks showing significant gains. Notable gainers include 4Front Ventures, Maple Leaf Green World, and 22nd Century Group. However, some stocks like Global Compliance and Currenc Group saw declines.

Portfolio Pulse from Benzinga Insights

September 23, 2024 | 8:30 pm

Viridian Capital Advisors highlights the importance of considering hidden debt in cannabis company valuations. Companies like Planet 13 Holdings and MariMed saw valuation increases when hidden debts were factored in, while others like Schwazze and Green Thumb Industries showed minimal changes, indicating cleaner balance sheets.

Portfolio Pulse from Nicolás Jose Rodriguez

September 22, 2024 | 4:19 pm

On September 20, 2024, several cannabis stocks experienced significant price movements. OrganiGram Holdings (NASDAQ:OGI) saw a 3.26% increase, while Corbus Pharmaceuticals (NASDAQ:CRBP) dropped 61.70%. Other notable movements include Village Farms Intl (NASDAQ:VFF) down 9.18% and GrowGeneration (NASDAQ:GRWG) down 5.12%.

Portfolio Pulse from Benzinga Insights

September 20, 2024 | 8:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.